
|Videos|December 15, 2021
iPLEDGE and Isotretinoin: What Happened?
Author(s)Linda Stocum, Associate Editor
In this video interview, Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, explains what happened with the iPLEDGE website.
Advertisement
In this first part of a video interview with Klint Peebles, MD, FAAD, co-chair of the AAD LGBTQ/SGM Expert Resource Group, Peebles explains the history of iPLEDGE and what may have led to the current difficulties that physicians, pharmacies, and patients are dealing with.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
3
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
4
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
5











